logo
Plus   Neg
Share
Email

Agios Pharmaceuticals Files For IPO Of Up To $86 Mln

Biopharmaceutical company Agios Pharmaceuticals Inc has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $86 million in an initial public offering of common stock. The company did not specify the number of shares to be sold and the price range for the proposed offering.

The Cambridge, Massachusetts-based company said in a preliminary prospectus that it intends to list its common stock on the Nasdaq under the symbol "AGIO".

The company, which was founded in 2007, specified that JP Morgan and Goldman Sachs & Co are lead underwriters in the IPO.

In April 2010, Agios entered into a collaboration agreement with Celgene corp (CELG.O) on a program focused on cancer metabolism.

Agios reported a net loss of $7.2 million on revenue of $6.3 million for the quarter ended March 31, according to the filing.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Nike Inc. (NKE), the world's largest athletic shoes and apparel maker, Tuesday reported a first-quarter profit that increased from a year ago and trumped Wall Street estimates, driven largely by more-than-expected revenues and strong margins. Beaverton, Oregon-based Nike's first-quarter profit rose... German auto giant BMW (BMW.L, BAMXF.PK, BAMXY.PK) Tuesday lowered its earnings and revenue guidance for the full year 2018, hurt largely by emissions-related costs, product recalls and ongoing global trade war. Automotive segment revenues are now expected to be slightly lower than the previous year.... Walt Disney World is introducing a new ticket pricing system in order to better distribute attendance at its theme parks throughout the year. The company plans to begin pricing tickets for its theme parks based on dates so as to reflect the expected demand on specific days. Disney said Monday that beginning October 16, guests will be able to access its new online vacation-booking portal.
Follow RTT